Teprenone, an anti-ulcer agent, increases gastric mucosal mucus level via nitric oxide in rats

Japanese Journal of Pharmacology

Volumn 78, Issue 4, 1998, Pages 519-522

  Nishida, Keiji ^a   Ohta, Yoshiji ^a   Ishiguro, Isao ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric mucus; Nitric oxide synthase; Teprenone

Indexed keywords

ANTIULCER AGENT; HEXOSAMINE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TEPRENONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STOMACH MUCOSA; STOMACH MUCUS;

EID: 0032422271     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.519     Document Type: Article

References (15)

1. Murakami M, Oketani K, Fujisaki H, Wakabayashi T and Ohgo T: Antiulcer effect of geranylgeranylacetone, a new acyclic polyisoprenoid on experimentally induced gastric and duodenal ulcers in rats. Arzneimittelforschung 31, 799-804 (1981)
2. Kunisaki C and Sugiyama M: Effect of teprenone on acute gastric mucosal lesions induced by cold-restraint stress. Digestion 53, 45-53 (1992)
3. Seno K, Joh T, Yokoyama Y and Itoh M: Role of mucus in gastric mucosal injury induced by local ischemia/reperfusion. J Lab Clin Med 126, 287-293 (1995)
4. Terano A, Hiraishi H, Ota S and Sugimoto T: Geranylgeranyl-acetone, a novel anti-ulcer drug, stimulates mucus synthesis and secretion in rat gastric cultured cells. Digestion 33, 206-210 (1986)
5. Miller TA: Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 245, G601-G623 (1983)
6. Terano A, Shiga J, Mutoh H, Hiraishi H, Shiina S, Kurita M, Ota S, Itoh Y and Sugimoto T: Tetraprenylacetone promotes healing process of ethanol-induced gastric damage in the rat. Jpn J Pharmacol 55, 115-120 (1991)
7. Brown JF, Keates AC, Hanson PJ and Whittle BJ: Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol 265, G418-G422 (1993)
8. Ichikawa T, Ishihara K, Kusakabe T, Kurihara M, Kawakami T, Takenaka T, Saigenji K and Hotta K: Distinct effects of tetragastric, histamine, and CCh on rat gastric mucin synthesis and contribution of NO. Am J Physiol 274, G138-G146 (1998)
9. Neuhaus OW and Letzring M: Determination of hexosamine in conjunction with electrophoresis. Anal Chem 29, 1230-1233 (1957)
10. Kitagawa H, Takeda F and Kohei H: A simple method for estimation of gastric mucus and effects of antinulcerogenic agents on the decrease in mucus during water-immersion stress in rats. Arzneimittelforschung 36, 1240-1244 (1986)
11. Feelisch M and Noack EA: Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol 139, 19-30 (1987)
12. 15N]-nitrate in biological fluids. Anal Biochem 126, 131-138 (1982)
13. Moncada S, Palmer RM and Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-142 (1991)
14. Lamarque D and Whittle BJ: Involvement of superoxide and xanthine oxidase in neutrophil-independent rat gastric damage induced by NO donors. Br J Pharmacol 116, 1843-1848 (1995)
15. Takeuchi K, Ueki S and Okabe S: Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 31, 1114-1122 (1986)